Acceleration of confirmed coronary artery disease among HIV-infected patients on potent antiretroviral therapy

AIDS

Volumn 14, Issue 17, 2000, Pages 2790-2792

  Friedl, Andrée C ^a   Attenhofer Jost, Christine H ^b   Schalcher, Christoph ^b   Amann, F Wolfgang ^b   Flepp, Markus ^a   Jenni, Rolf ^b   Linka, André ^b   Weber, Rainer ^a  

^a Division of Infectious Diseases   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; LIPID; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPID BLOOD LEVEL; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CORONARY DISEASE; DATABASES; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HUMANS; HYPERLIPIDEMIAS; MALE; MYOCARDIAL INFARCTION; SMOKING;

EID: 0034495664     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200012010-00021     Document Type: Article

References (17)

1. Vascular complications associated with use of HIV protease inhibitors
2. Is treatment with ritonavir a risk factor for myocardial infarction in HIV-infected patients?
3. Myocardial infarction in HIV-infected men receiving protease inhibitors
4. Vascular complications associated with use of HIV protease inhibitors
5. Left main coronary artery disease in a 40-year-old man receiving HIV protease inhibitors
6. Severe premature coronary artery disease with protease inhibitors
7. Severe coronary artery disease in a young HIV-infected man with no cardiovascular risk factor who was treated with indinavir
8. Vascular complications associated with use of HIV protease inhibitors
9. Accelerated coronary atherosclerosis and arteriosclerosis in young human-immunodeficiency-virus-positive patients
10. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors
11. Epidemiological and clinical aspects of the metabolic complications of HIV infection the fat redistribution syndrome
12. Vascular complications associated with use of HIV protease inhibitors
13. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study
14. Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy
15. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment
16. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease
17. Identification of high-risk groups and comparison with other cardiovascular intervention trials